Details for New Drug Application (NDA): 088693
✉ Email this page to a colleague
NDA 088693 describes TRYMEX, which is a drug marketed by Savage Labs and is included in five NDAs. Additional details are available on the TRYMEX profile page.
The generic ingredient in TRYMEX is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
The generic ingredient in TRYMEX is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 088693
| Tradename: | TRYMEX |
| Applicant: | Savage Labs |
| Ingredient: | triamcinolone acetonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088693
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 0.025% | ||||
| Approval Date: | Aug 2, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
